Egyptian Journal of Chest Disease and Tuberculosis (Jan 2021)

Dilemma of antiviral treatment in coronavirus 2019

  • Hossam H Masoud

DOI
https://doi.org/10.4103/ejcdt.ejcdt_2402_20
Journal volume & issue
Vol. 70, no. 5
pp. 4 – 6

Abstract

Read online

There are four classes of Coronaviruses designated as alpha, beta, gamma and delta. CoV-2 attacks the lower respiratory system to cause severe pneumonia, but it may also affect other organs leading to multiple organ failure. The choice for antiviral treatment for CoV-2 depends on the timing and the severity of the case. Although there is no antiviral designed specifically for treating corona virus, several agents are tried such as hydroxychloroquine, Remdesivir, Lopinavir/Ritonavir, and Favipiravir. The mechanism of each drug is diacussed in detail below. In addition, ivermectin has started to emerge as a new candidate therapeutic against SARS-CoV-2/ COVID-19.

Keywords